Patients presentations |
N 0 |
miR-335 |
miR-24 |
miR-320 |
miR-548d-5p |
miR-342-5p |
miR-15a |
miR-342-3p |
miR-29a |
miR-451 |
miR-30b |
miR-337-5p |
miR-486-3p |
Age |
≥40 years |
9 |
0.413 |
0.698 |
0.098 |
0.874 |
0.074 |
0.354 |
0.187 |
0.249 |
0.193 |
0.094 |
0.297 |
0.774 |
<40 years |
11 |
|
|
|
|
|
|
|
|
|
|
|
|
Menopausal State |
Premenopausal |
10 |
0.224 |
0.154 |
0.347 |
0.056 |
0.634 |
0.157 |
0.012 |
0.192 |
0.259 |
0.454 |
0.576 |
0.312 |
Postmenopausal |
10 |
|
|
|
|
|
|
|
|
|
|
|
|
Parity |
yes |
12 |
0.881 |
0.844 |
0.816 |
0.95 |
0.359 |
0.935 |
0.72 |
0.457 |
0.617 |
0.892 |
0.524 |
0.120 |
No |
8 |
|
|
|
|
|
|
|
|
|
|
|
|
ER status |
Negative |
3 |
0.76 |
0.074 |
0.282 |
0.199 |
0.454 |
0.208 |
0.108 |
0.456 |
0.676 |
0.35 |
0.767 |
0.697 |
Positive |
17 |
|
|
|
|
|
|
|
|
|
|
|
|
PR status |
Negative |
4 |
0.97 |
0.329 |
0.43 |
0.302 |
0.371 |
0.483 |
0.79 |
0.812 |
0.405 |
0.413 |
0.347 |
0.297 |
Positive |
16 |
|
|
|
|
|
|
|
|
|
|
|
|
Her2 overexpression |
Negative |
13 |
0.989 |
0.178 |
0.138 |
0.394 |
0.304 |
0.001 |
0.058 |
0.053 |
0.074 |
0.421 |
0.39 |
0.297 |
Positive |
7 |
|
|
|
|
|
|
|
|
|
|
|
|
Lymph Node Involvement |
No |
2 |
0.09 |
0.682 |
0.351 |
0.671 |
0.487 |
0.13 |
0.102 |
0.241 |
0.251 |
0.935 |
0.925 |
0.061 |
Yes |
18 |
|
|
|
|
|
|
|
|
|
|
|
|
Tumor Size |
T1-T2 |
0 |
0.884 |
0.091 |
0.682 |
0.926 |
0.35 |
0.671 |
0.487 |
0.13 |
0.102 |
0.241 |
0.215 |
0.935 |
T3-T4 |
20 |
|
|
|
|
|
|
|
|
|
|
|
|
Tumor Grade |
II |
9 |
0.273 |
0.49 |
0.532 |
0.153 |
0.344 |
0.859 |
0.83 |
0.721 |
0.659 |
0.799 |
0.678 |
0.289 |
III |
11 |
|
|
|
|
|
|
|
|
|
|
|
|
Metastasis |
No |
14 |
0.819 |
0.028 |
0.005 |
0.921 |
0.68 |
0.151 |
0.479 |
0.712 |
0.211 |
0.187 |
0.405 |
0.736 |
Yes |
6 |
|
|
|
|
|
|
|
|
|
|
|
|
Bold letters represent p < 0.05, significant. |
|